Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 145Lymphoma 104Lymphoma, Large B-Cell, Diffuse 76Sarcoma 62Hodgkin Disease 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Burkitt Lymphoma 36Triple Negative Breast Neoplasms 31Lymphoma, Non-Hodgkin 29Lymphoma, Mantle-Cell 27Leukemia 25Neoplasms 22Lymphoma, Follicular 22Neoplasm Metastasis 21Multiple Myeloma 21Neuroblastoma 20Carcinoma, Hepatocellular 18Ovarian Neoplasms 16Lymphoma, B-Cell 16Liver Neoplasms 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Urinary Bladder Neoplasms 12Osteosarcoma 12Lymphoma, T-Cell, Peripheral 11Lymphoma, Large-Cell, Anaplastic 11Inflammatory Breast Neoplasms 11Breast Neoplasms, Male 11Prostatic Neoplasms 10Dendritic Cell Sarcoma, Interdigitating 10Lymphoma, Large-Cell, Immunoblastic 9

Interventions

Temozolomide 7Radiotherapy 3Everolimus 3nimotuzumab 2Erlotinib Hydrochloride 2Cyclophosphamide 2Bevacizumab 2tovorafenib 1ribociclib 1palbociclib 1olutasidenib 1antineoplaston AS 2-1 1antineoplaston A10 1Vinorelbine 1Valproic Acid 1Topotecan 1TIC10 compound 1Radiation 1Proto-Oncogene Proteins c-akt 1Phosphatidylinositol 3-Kinases 1Panobinostat 1Lomustine 1Irinotecan 1Injections 1GDC-0084 1Etoposide 1Drug Therapy 1Doxorubicin 1Diphtheria-Tetanus Vaccine 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Diffuse Intrinsic Pontine Glioma × Doxorubicin × Clear all
NCT02758366 2021-02-09

Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma

Meyer Children's Hospital IRCCS

Phase 2 Terminated
21 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Neoplasms, Neuroepithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡